New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers

New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers Eduardo Diaz-Rubio Oncologist 2004; 9: 282-294 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the need for more effective chemotherapy regimens for the treatment of advanced pancreatic, gastric, and colorectal cancer. Select the most appropriate treatment regimen in each of these categories based on the best available evidence. Identify the many new agents that target novel molecules in these cancers that are being explored in combination with conventional chemotherapy regimens. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: May 28, 2004 Most Recent Review: May 28, 2004* Most Recent Update: May 28, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.